These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
506 related articles for article (PubMed ID: 32077747)
1. Long Noncoding RNA Xie F; Xie G; Sun Q Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747 [No Abstract] [Full Text] [Related]
2. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis. Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p. Jiang H; Huang G; Zhao N; Zhang T; Jiang M; He Y; Zhou X; Jiang X J Exp Clin Cancer Res; 2018 Jul; 37(1):169. PubMed ID: 30045766 [TBL] [Abstract][Full Text] [Related]
5. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression. Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p. Li D; Tang X; Li M; Zheng Y J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1. Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129 [TBL] [Abstract][Full Text] [Related]
8. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p. Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911 [TBL] [Abstract][Full Text] [Related]
9. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis. Jia P; Wei E; Liu H; Wu T; Wang H IUBMB Life; 2020 Dec; 72(12):2627-2636. PubMed ID: 33031637 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis. Wu C; Lin W; Fu F Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677 [TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A. Zhou C; Chen Z; Peng C; Chen C; Li H Cancer Biother Radiopharm; 2021 Mar; 36(2):211-219. PubMed ID: 32391716 [No Abstract] [Full Text] [Related]
12. DGUOK-AS1 promotes cell proliferation in cervical cancer via acting as a ceRNA of miR-653-5p. Wu N; Song H; Ren Y; Tao S; Li S Cell Biochem Funct; 2020 Oct; 38(7):870-879. PubMed ID: 32283566 [TBL] [Abstract][Full Text] [Related]
13. The regulatory network of lncRNA DLX6-AS1/miR-149-5p/ERP44 is possibly related to the progression of preeclampsia. Liu R; Wang X; Yan Q Placenta; 2020 Apr; 93():34-42. PubMed ID: 32250737 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS. Tian Y; Wang YR; Jia SH Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7307-7313. PubMed ID: 31539117 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2. Hou S; Zhang X; Yang J Exp Cell Res; 2022 Jan; 410(1):112929. PubMed ID: 34793775 [TBL] [Abstract][Full Text] [Related]
16. LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis. Shao S; Wang C; Wang S; Zhang H; Zhang Y Biomed Pharmacother; 2019 Sep; 117():109082. PubMed ID: 31212131 [TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG6 accelerates nasopharyngeal carcinoma progression via modulating miR-26a-5p/ARPP19 axis. Yin X; Gu X; Li F; Ye F; Liu F; Wang W Bioorg Med Chem Lett; 2021 May; 40():127955. PubMed ID: 33744438 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Huang Y; Ni R; Wang J; Liu Y Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440 [TBL] [Abstract][Full Text] [Related]
19. LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2. Yan K; Hu C; Liu C; Chu G; Wang X; Ma S; Li L Histol Histopathol; 2023 Jul; 38(7):823-835. PubMed ID: 36444938 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway. Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]